Brochure | June 1, 2023

LEAP™ Advanced Therapy Platform

Source: BioCentriq
Cancer Cells GettyImages-1339282297

At BioCentriq, we want to support the development and, ultimately, approval of life-changing therapies. Our LEAP™ Advanced Therapy Platform was developed to support our goal by leveraging proven expertise and assets to reduce the time to clinic and reach patients in record time.

This platform utilizes established manufacturing processes and analytical methods to greatly reduce process development and scale-up timelines. Pre-existing batch records, documentation, and training programs mean moving from contract to clinic in six months. Data demonstrating the efficacy of our LEAP-NK™ platform can be viewed here.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma